"Lysophospholipids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of PHOSPHATIDIC ACIDS that lack one of its fatty acyl chains due to its hydrolytic removal.
| Descriptor ID |
D008246
|
| MeSH Number(s) |
D10.570.755.375.760.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lysophospholipids".
Below are MeSH descriptors whose meaning is more specific than "Lysophospholipids".
This graph shows the total number of publications written about "Lysophospholipids" by people in this website by year, and whether "Lysophospholipids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 1 | 5 |
| 1996 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 5 | 2 | 7 |
| 2001 | 4 | 0 | 4 |
| 2002 | 4 | 0 | 4 |
| 2003 | 8 | 2 | 10 |
| 2004 | 3 | 1 | 4 |
| 2005 | 3 | 0 | 3 |
| 2006 | 6 | 3 | 9 |
| 2007 | 6 | 2 | 8 |
| 2008 | 3 | 0 | 3 |
| 2009 | 4 | 2 | 6 |
| 2010 | 4 | 2 | 6 |
| 2011 | 3 | 0 | 3 |
| 2012 | 5 | 3 | 8 |
| 2013 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 2 | 2 |
| 2018 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lysophospholipids" by people in Profiles.
-
Mucosal and Plasma Metabolomes in New-onset Paediatric Inflammatory Bowel Disease: Correlations with Disease Characteristics and Plasma Inflammation Protein Markers. J Crohns Colitis. 2023 Apr 03; 17(3):418-432.
-
Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts. Cancer Lett. 2019 02 01; 442:464-474.
-
How close they were to success. J Thorac Cardiovasc Surg. 2018 08; 156(2):918-919.
-
LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response. Cancer Res. 2018 04 15; 78(8):1923-1934.
-
Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease. FASEB J. 2018 05; 32(5):2855-2865.
-
Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder. Eur Urol Focus. 2018 12; 4(6):907-915.
-
Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease. Hum Mol Genet. 2017 04 01; 26(7):1305-1317.
-
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition. Cancer Cell. 2016 Dec 12; 30(6):879-890.
-
Autosomal-Recessive Hearing Impairment Due to Rare Missense Variants within S1PR2. Am J Hum Genet. 2016 Feb 04; 98(2):331-8.
-
Restoration of Na+/H+ exchanger NHE3-containing macrocomplexes ameliorates diabetes-associated fluid loss. J Clin Invest. 2015 Sep; 125(9):3519-31.